SEC Filings
For all investor or media inquiries, visit https://www.adaptimmune.com/contact.
Filing date | Description | Form | Filing Group | View |
---|---|---|---|---|
Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
View HTML | |
Filing of certain prospectuses and communications in connection with business combination transactions |
425 |
Other
|
View HTML | |
Filing by person(s) reporting owned shares of common stock in a public company >5% |
SC 13D |
Other
|
View HTML | |
EFFECT |
EFFECT |
Other
|
View HTML | |
EFFECT |
EFFECT |
Other
|
View HTML | |
EFFECT |
EFFECT |
Other
|
View HTML | |
EFFECT |
EFFECT |
Other
|
View HTML | |
EFFECT |
EFFECT |
Other
|
View HTML | |
EFFECT |
EFFECT |
Other
|
View HTML | |
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |
Registration Statements
|
View HTML |
Displaying 261 - 270 of 314 results
Data provided by Kaleidoscope.